A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

A rehab firm will pay a cash settlement to an occupational therapist it fired when the worker declined a COVID-19 vaccination ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...